Literature DB >> 10328871

Binding of interferon gamma by glycosaminoglycans: a strategy for localization and/or inhibition of its activity.

R Fernandez-Botran1, J Yan, D E Justus.   

Abstract

Glycosaminoglycans (GAGs) are a group of negatively charged molecules present in many tissues as components of the extracellular matrix, basement and cellular membranes. This work analysed the ability of this group of substances to interact with human interferon gamma and the effect of those interactions on its biologic activity. A variety of GAGs (heparin, heparan sulfate, chondroitin sulfate and hyaluronic acid), and a related sulfated polysaccharide (dextran sulfate), were found to interact with IFN-gamma as determined by inhibition of the binding of [125I]IFN-gamma to COLO-205 cells and binding to wells coated with GAGs. These interactions were inhibited by synthetic peptides mimicking the sequences of the basic amino acid cluster located at the C-terminal end of mouse and human IFN-gamma, or by poly-L-lysine, suggesting that ionic interactions between the positively-charged C-terminus and negatively charged groups in GAGs were involved. IFN-gamma molecules bound to plate-immobilized or endothelial cell surface GAGs retained biological activity, since they could induce major histocompatibility complex (MHC) class II expression on COLO-205 cells, suggesting that cell surface GAGs might be able to present IFN-gamma to its receptors. These results suggest important regulatory roles for GAGs on the activity of IFN-gamma in vivo. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10328871     DOI: 10.1006/cyto.1998.0438

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  9 in total

Review 1.  Proteoglycans: key regulators of pulmonary inflammation and the innate immune response to lung infection.

Authors:  Sean Gill; Thomas N Wight; Charles W Frevert
Journal:  Anat Rec (Hoboken)       Date:  2010-06       Impact factor: 2.064

2.  A decorin-deficient matrix affects skin chondroitin/dermatan sulfate levels and keratinocyte function.

Authors:  Katerina Nikolovska; Jana K Renke; Oliver Jungmann; Kay Grobe; Renato V Iozzo; Alina D Zamfir; Daniela G Seidler
Journal:  Matrix Biol       Date:  2014-01-18       Impact factor: 11.583

Review 3.  Proteoglycans as Immunomodulators of the Innate Immune Response to Lung Infection.

Authors:  Inkyung Kang; Mary Y Chang; Thomas N Wight; Charles W Frevert
Journal:  J Histochem Cytochem       Date:  2018-01-12       Impact factor: 2.479

Review 4.  Defining the versican interactome in lung health and disease.

Authors:  Fengying Tang; Jourdan E Brune; Mary Y Chang; Stephen R Reeves; William A Altemeier; Charles W Frevert
Journal:  Am J Physiol Cell Physiol       Date:  2022-06-01       Impact factor: 5.282

5.  Heparin and structurally related polymers attenuate eotaxin-1 (CCL11) release from human airway smooth muscle.

Authors:  V Kanabar; C P Page; D E Simcock; C Karner; K Mahn; B J O'Connor; S J Hirst
Journal:  Br J Pharmacol       Date:  2008-04-21       Impact factor: 8.739

6.  Cutting edge: Direct recognition of infected cells by CD4 T cells is required for control of intracellular Mycobacterium tuberculosis in vivo.

Authors:  Smita Srivastava; Joel D Ernst
Journal:  J Immunol       Date:  2013-07-01       Impact factor: 5.422

7.  Decorin potentiates interferon-γ activity in a model of allergic inflammation.

Authors:  Carla Bocian; Ann-Kathrin Urbanowitz; Rick T Owens; Renato V Iozzo; Martin Götte; Daniela G Seidler
Journal:  J Biol Chem       Date:  2013-03-04       Impact factor: 5.157

8.  Modulation of Interleukin-12 activity in the presence of heparin.

Authors:  Srinivas Jayanthi; Bhanu Prasanth Koppolu; Khue G Nguyen; Sean G Smith; Barbara K Felber; Thallapuranam Krishnaswamy Suresh Kumar; David A Zaharoff
Journal:  Sci Rep       Date:  2017-07-13       Impact factor: 4.379

9.  GPC3 expression in mouse ovarian cancer induces GPC3‑specific T cell-mediated immune response through M1 macrophages and suppresses tumor growth.

Authors:  Chenhong Luo; Kiyosumi Shibata; Shiro Suzuki; Hiroaki Kajiyama; Takeshi Senga; Yoshihiro Koya; Mina Daimon; Mamoru Yamashita; Fumitaka Kikkawa
Journal:  Oncol Rep       Date:  2014-07-02       Impact factor: 3.906

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.